{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:57:31Z","timestamp":1789073851686,"version":"build-2803163510"},"reference-count":25,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alpha Psychiatry"],"abstract":"<jats:p>Objective: This study analyses trends in the prescription and usage of benzodiazepines (BZDs) and Z-drugs within specialised medical institutions and emergency outpatient services in China from 2015 to 2021, focusing on demographics and prescribing patterns to promote better management practices. Methods: A retrospective study was conducted from 2015 to 2021, reviewing prescription information and population characteristics from 10 hospitals, including specialised psychiatric institutions and general hospitals in Zhejiang, Jiangsu, and Shanghai. The study analysed a total of 33,569 valid prescriptions. Results: There was a noticeable increase in the total defined daily doses of both benzodiazepines and Z-drugs, with significant variations among different drugs. Lorazepam and zopiclone showed the most substantial increases in usage. Drugs like clonazepam and lorazepam were predominantly prescribed, indicating specific patterns in disease management, particularly for insomnia and anxiety. Conclusions: This study reveals a significant increase in benzodiazepine and Z-drug prescriptions, particularly among elderly and female patients. The findings highlight the need for targeted interventions and policy reforms to ensure safe prescribing practices and mitigate the risks associated with long-term use in these vulnerable populations.<\/jats:p>","DOI":"10.31083\/ap38792","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:46:10Z","timestamp":1741340770000},"source":"Crossref","is-referenced-by-count":7,"title":["Trends in Benzodiazepine and Z-Drug Prescriptions in Eastern China (2015\u20132021)"],"prefix":"10.31083","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3723-7419","authenticated-orcid":true,"given":"Qian","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Seventh People\u2019s Hospital of Shaoxing, 312000 Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-4314","authenticated-orcid":true,"given":"Hualiang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Seventh People\u2019s Hospital of Shaoxing, 312000 Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Goodchild CS. GABA receptors and benzodiazepines. British Journal of Anaesthesia. 1993; 71: 127\u2013133.","DOI":"10.1093\/bja\/71.1.127."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Liebrenz M, Schneider M, Buadze A, Gehring MT, Dube A, Caflisch C. High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients\u2019 Perceptions on Initiation, Reasons for Use, and Obtainment. PloS One. 2015; 10: e0142057.","DOI":"10.1371\/journal.pone.0142057."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Jembrek MJ, Vlainic J. GABA Receptors: Pharmacological Potential and Pitfalls. Current Pharmaceutical Design. 2015; 21: 4943\u20134959.","DOI":"10.2174\/1381612821666150914121624."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Chauhan V, Shukla SK, Sharma GP. Abuse of z-drugs and its challenges to the society. International Journal of Medical Toxicology & Legal Medicine. 2020; 23: 191\u2013205.","DOI":"10.5958\/0974-4614.2020.00029.7."},{"key":"ref5","unstructured":"World Drug Report 2018. Available at: https:\/\/www.unodc.org\/wdr2018 (Accessed: 7 November 2022)."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Luka\u010di\u0161inov\u00e1 A, Fialov\u00e1 D, Peel NM, Hubbard RE, Brkic J, Onder G, et al. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study. BMC Geriatrics. 2021; 21: 277.","DOI":"10.1186\/s12877-021-02213-x."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Torres-Bondia F, de Batlle J, Galv\u00e1n L, Buti M, Barb\u00e9 F, Pi\u00f1ol-Ripoll G. Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015. BMC Public Health. 2020; 20: 818.","DOI":"10.1186\/s12889-020-08984-z."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"G\u00e9rardin M, Rousselet M, Caillet P, Grall-Bronnec M, Lou\u00e9 P, Jolliet P, et al. French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol. BMJ Open. 2019; 9: e027443.","DOI":"10.1136\/bmjopen-2018-027443."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Blanco C, Han B, Jones CM, Johnson K, Compton WM. Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States. The Journal of Clinical Psychiatry. 2018; 79: 18m12174.","DOI":"10.4088\/JCP.18m12174."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zhang B, Yan XY, Zhang XY, Jia ZW. Research progress on current situation and preventive measures for the narcotic and psychotropic drugs abuse in the elderly. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 615\u2013620.  (In Chinese)","DOI":"10.3760\/cma.j.cn112338-20190723-00542."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Li Z, Li J, Hu Y, Yan Y, Tang S, Ma R, et al. Evaluation of pharmaceutical consumption between urban and suburban catchments in China by wastewater-based epidemiology. Environmental Research. 2024; 250: 118544.","DOI":"10.1016\/j.envres.2024.118544."},{"key":"ref12","unstructured":"Yan Y, Liu P. Investigation of the use of benzodiazepines in prescriptions from the outpatient department of the General Hospital of the People\u2019s Liberation Army. Journal of Epidemiology of Medicines. 1997; 4. (In Chinese)"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Marra EM, Mazer-Amirshahi M, Brooks G, van den Anker J, May L, Pines JM. Benzodiazepine Prescribing in Older Adults in U.S. Ambulatory Clinics and Emergency Departments (2001-10). Journal of the American Geriatrics Society. 2015; 63: 2074\u20132081.","DOI":"10.1111\/jgs.13666."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Bonnet U, McAnally HB. How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z-hypnotic drugs. Human Psychopharmacology. 2022; 37: e2822.","DOI":"10.1002\/hup.2822."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Woods A, Begum M, Gonzalez-Chica D, Bernardo C, Hoon E, Stocks N. Long-term benzodiazepines and z-drug prescribing in Australian general practice between 2011 and 2018: A national study. Pharmacology Research & Perspectives. 2022; 10: e00896.","DOI":"10.1002\/prp2.896."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Gonzalez-Chica D, Begum M, Bernardo C, Hoon E, Sweetman A, Stocks N. Trends and patterns of benzodiazepines and Z-drugs prescriptions in Australian general practice: A national study (2011-2018). Drug and Alcohol Review. 2023; 42: 427\u2013438.","DOI":"10.1111\/dar.13561."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K. Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. British Journal of Clinical Pharmacology. 2018; 84: 1354\u20131363.","DOI":"10.1111\/bcp.13570."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Uthayakumar S, Tadrous M, Vigod SN, Kitchen SA, Gomes T. The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada. Depression and Anxiety. 2022; 39: 156\u2013162.","DOI":"10.1002\/da.23228."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Windle A, Elliot E, Duszynski K, Moore V. Benzodiazepine prescribing in elderly Australian general practice patients. Australian and New Zealand Journal of Public Health. 2007; 31: 379\u2013381.","DOI":"10.1111\/j.1753-6405.2007.00091.x."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Lefebvre-Durel C, Bailly I, Hunault J, Jovic L, Novic M, Vorspan F, et al. Benzodiazepine and Z drug cessation in elderly patients: A qualitative study on the perception of healthcare providers and the place of advanced practice nurses. International Journal of Mental Health Nursing. 2021; 30: 653\u2013666.","DOI":"10.1111\/inm.12831."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research. Drugs in R&D. 2017; 17: 493\u2013507.","DOI":"10.1007\/s40268-017-0207-7."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Lee JS. Necessary evil or systemic failure of care? Use of benzodiazepine and antipsychotic medications in older people seeking emergency department care. Journal of the American Geriatrics Society. 2022; 70: 698\u2013700.","DOI":"10.1111\/jgs.17664."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015; 72: 136\u2013142.","DOI":"10.1001\/jamapsychiatry.2014.1763."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Hockenhull J, Black JC, Haynes CM, Rockhill K, Dargan PI, Dart RC, et al. Nonmedical use of benzodiazepines and Z-drugs in the UK. British Journal of Clinical Pharmacology. 2021; 87: 1676\u20131683.","DOI":"10.1111\/bcp.14397."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Chan WL, Wood DM, Dargan PI. Prescription medicine misuse in the Asia-Pacific region: An evolving issue? British Journal of Clinical Pharmacology. 2021; 87: 1660\u20131667.","DOI":"10.1111\/bcp.14638."}],"container-title":["Alpha Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/AP\/26\/1\/10.31083\/AP38792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:48:26Z","timestamp":1741340906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/AP\/26\/1\/10.31083\/AP38792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2757-8038(25)02002-6"],"URL":"https:\/\/doi.org\/10.31083\/ap38792","relation":{},"ISSN":["2757-8038"],"issn-type":[{"value":"2757-8038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"38792"}}